Unknown

Dataset Information

Intrahepatic Cholangiocarcinoma with Lymph Node Metastasis: Treatment-Related Outcomes and the Role of Tumor Genomics in Patient Selection.


ABSTRACT:

Purpose

Lymph node metastasis (LNM) drastically reduces survival after resection of intrahepatic cholangiocarcinoma (IHC). Optimal treatment is ill defined, and it is unclear whether tumor mutational profiling can support treatment decisions.

Experimental design

Patients with liver-limited IHC with or without LNM treated with resection (N = 237), hepatic arterial infusion chemotherapy (HAIC; N = 196), or systemic chemotherapy alone (SYS; N = 140) at our institution between 2000 and 2018 were included. Genomic sequencing was analyzed to determine whether genetic alterations could stratify outcomes for patients with LNM.

Results

For node-negative patients, resection was associated with the longest median overall survival [OS, 59.9 months; 95% confid

SUBMITTER: Jolissaint JS 

PROVIDER: S-EPMC8282702 | biostudies-literature | 2021 Jul

REPOSITORIES: biostudies-literature